ADRENOCEPTOR BLOCKERS Flashcards
ALPHA BLOCKING DRUGS
All active by
Oral route
Parenteral route
IRREVERSIBLE LONG-ACTING
Prototype
Only slightly alpha1 selective
Short elimination half life
PHENOXYBENZAMINE
IRREVERSIBLE LONG-ACTING
Long duration of action (48 hours)
Binds covalently to its receptors
PHENOXYBENZAMINE
REVERSIBLE SHORT-ACTING
Prototype
Nonselective (alpha1=alpha2)
PHENTOLAMINE
PHENTOLAMINE
Duration of action
Oral ( —- hours)
IV ( —– minutes)
2-4 hours oral
20-40 minutes IV
ALPHA1 SELECTIVE
Prototype
Selective reversible alpha1 blocker
PRAZOSIN
PRAZOSIN
Duration of action —- hours
8-24
Prototype
Selective alpha2 competitive blockers
Used primarily in research application
YOHIMBINE, RAUWOLSCINE
Most important effects are on the CVS system
Reduction in cardiovascular tone
Reduction of both arterial and venous
pressure (decrease in BP)
NONSELECTIVE BLOCKERS
EFFECTS
NONSELECTIVE BLOCKERS
-Cause baroreceptor reflex-mediated
tachycardia as a result of the drop
in mean arterial pressure (MAP)
-Tachycardia maybe exaggerated
Predictable result of the use of an
agonist in a patient who has received
an alpha-blocker
EPINEPHRINE REVERSAL
EFFECTS
NONSELECTIVE BLOCKERS
Not observed with phenylephrine
or NE because they lack sufficient
beta2 effects
EPINEPHRINE REVERSAL
Block alpha1 receptors much more effectively
Cause much less tachycardia than
the nonselective blockers when
reducing BP
SELECTIVE ALPHA1 BLOCKERS
CLINICAL USES
Limited clinical application
Presurgical treatment of pheochromocytoma
NONSELECTIVE ALPHA BLOCKERS
NONSELECTIVE ALPHA BLOCKERS
—– is used during the preparatory phase
Phenoxybenzamine
NONSELECTIVE ALPHA BLOCKERS
—– is used during surgery
Phentolamine
SELECTIVE ALPHA BLOCKERS
—- are used in hypertension
Prazosin, doxazosin, and terazosin
Used together with tamsulosin for urinary hesitancy and prevention of urinary retention with benign prostatic hyperplasia
SELECTIVE ALPHA BLOCKERS
TOXICITY
Main manifestation is
orthostatic hypotension
Competitive pharmacologic antagonists
Developed for chronic oral use
BETA BLOCKING DRUGS
prototype of beta blocking drugs
Propranolol
BETA BLOCKING DRUGS
Short-acting ester
Used only parenterally
ESMOLOL
BETA BLOCKING DRUGS
Longest acting beta-blocker
NADOLOL
BETA BLOCKING DRUGS
Less lipid soluble
Enter the CNS to a lesser extent
ACEBUTOLOL, ATENOLOL and NADOLOL
BETA BLOCKING DRUGS EFFECTS
1. CVS
Decrease BP
Antagonize renin secretion
(-) inotropic effect
(-) chronotropic effect
BETA BLOCKING DRUGS EFFECTS
2. RESPIRATORY
Bronchoconstriction
Increase airway resistance
BETA BLOCKING DRUGS EFFECTS
3. EYE
Decrease intraocular pressure
Decrease production of aqueous humor
BETA BLOCKING DRUGS EFFECTS
4. METABOLIC AND ENDOCRINE
Reduce insulin secretion
Caution for insulin dependent DM
BETA BLOCKING DRUGS
CLINICAL USES
Open-angle glaucoma Hypertension Angina Arrhythmias Chronic heart failure Pheochromocytoma